scholarly journals Hypoxia Epigenetically Confers Astrocytic Differentiation Potential on Human Pluripotent Cell-Derived Neural Precursor Cells

2017 ◽  
Vol 8 (6) ◽  
pp. 1743-1756 ◽  
Author(s):  
Tetsuro Yasui ◽  
Naohiro Uezono ◽  
Hideyuki Nakashima ◽  
Hirofumi Noguchi ◽  
Taito Matsuda ◽  
...  
Glia ◽  
2006 ◽  
Vol 55 (2) ◽  
pp. 224-232 ◽  
Author(s):  
Rivka Steinhart ◽  
Gila Kazimirsky ◽  
Hana Okhrimenko ◽  
Tamir Ben-Hur ◽  
Chaya Brodie

2013 ◽  
Vol 394 (12) ◽  
pp. 1623-1636 ◽  
Author(s):  
The Duy Nguyen ◽  
Darius Widera ◽  
Johannes Greiner ◽  
Janine Müller ◽  
Ina Martin ◽  
...  

Abstract Neural precursor cells (NPCs) are lineage-restricted neural stem cells with limited self-renewal, giving rise to a broad range of neural cell types such as neurons, astrocytes, and oligodendrocytes. Despite this developmental potential, the differentiation capacity of NPCs has been controversially discussed concerning the trespassing lineage boundaries, for instance resulting in hematopoietic competence. Assessing their in vitro plasticity, we isolated nestin+/Sox2+, NPCs from the adult murine hippocampus. In vitro-expanded adult NPCs were able to form neurospheres, self-renew, and differentiate into neuronal, astrocytic, and oligodendrocytic cells. Although NPCs cultivated in early passage efficiently gave rise to neuronal cells in a directed differentiation assay, extensively cultivated NPCs revealed reduced potential for ectodermal differentiation. We further observed successful differentiation of long-term cultured NPCs into osteogenic and adipogenic cell types, suggesting that NPCs underwent a fate switch during culture. NPCs cultivated for more than 12 passages were aneuploid (abnormal chromosome numbers such as 70 chromosomes). Furthermore, they showed growth factor-independent proliferation, a hallmark of tumorigenic transformation. In conclusion, our findings substantiate the lineage restriction of NPCs from adult mammalian hippocampus. Prolonged cultivation results, however, in enhanced differentiation potential, which may be attributed to transformation events leading to aneuploid cells.


PLoS ONE ◽  
2008 ◽  
Vol 3 (9) ◽  
pp. e3189 ◽  
Author(s):  
Izuho Hatada ◽  
Masakazu Namihira ◽  
Sumiyo Morita ◽  
Mika Kimura ◽  
Takuro Horii ◽  
...  

2017 ◽  
Vol 429 (1) ◽  
pp. 56-70 ◽  
Author(s):  
Gilda Guerrero-Flores ◽  
Aimée Bastidas-Ponce ◽  
Omar Collazo-Navarrete ◽  
Magdalena Guerra-Crespo ◽  
Luis Covarrubias

2021 ◽  
Vol 14 ◽  
Author(s):  
Michael Telias ◽  
Dalit Ben-Yosef

The canonical Wnt/β-catenin pathway is a master-regulator of cell fate during embryonic and adult neurogenesis and is therefore a major pharmacological target in basic and clinical research. Chemical manipulation of Wnt signaling during in vitro neuronal differentiation of stem cells can alter both the quantity and the quality of the derived neurons. Accordingly, the use of Wnt activators and blockers has become an integral part of differentiation protocols applied to stem cells in recent years. Here, we investigated the effects of the glycogen synthase kinase-3β inhibitor CHIR99021, which upregulates β-catenin agonizing Wnt; and the tankyrase-1/2 inhibitor XAV939, which downregulates β-catenin antagonizing Wnt. Both drugs and their potential neurogenic and anti-neurogenic effects were studied using stable lines human neural precursor cells (hNPCs), derived from embryonic stem cells, which can be induced to generate mature neurons by chemically-defined conditions. We found that Wnt-agonism by CHIR99021 promotes induction of neural differentiation, while also reducing cell proliferation and survival. This effect was not synergistic with those of pro-neural growth factors during long-term neuronal differentiation. Conversely, antagonism of Wnt by XAV939 consistently prevented neuronal progression of hNPCs. We show here how these two drugs can be used to manipulate cell fate and how self-renewing hNPCs can be used as reliable human in vitro drug-screening platforms.


2008 ◽  
Vol 24 (3-4) ◽  
pp. E8 ◽  
Author(s):  
Karim Mukhida ◽  
Behnam A. Baghbaderani ◽  
Murray Hong ◽  
Matthew Lewington ◽  
Timothy Phillips ◽  
...  

Object Fetal tissue transplantation for Parkinson disease (PD) has demonstrated promising results in experimental and clinical studies. However, the widespread clinical application of this therapeutic approach is limited by a lack of fetal tissue. Human neural precursor cells (HNPCs) are attractive candidates for transplantation because of their long-term proliferation activity. Furthermore, these cells can be reproducibly expanded in a standardized fashion in suspension bioreactors. In this study the authors sought to determine whether the survival, differentiation, and migration of HNPCs after transplantation depended on the region of precursor cell origin, intracerebral site of transplantation, and duration of their expansion. Methods Human neural precursor cells were isolated from the telencephalon, brainstem, ventral mesencephalon, and spinal cord of human fetuses 8–10 weeks of gestational age, and their differentiation potential characterized in vitro. After expansion in suspension bioreactors, the HNPCs were transplanted into the striatum and substantia nigra of parkinsonian rats. Histological analyses were performed 7 weeks posttransplantation. Results The HNPCs isolated from various regions of the neuraxis demonstrated diverse propensities to differentiate into astrocytes and neurons and could all successfully expand under standardized conditions in suspension bioreactors. At 7 weeks posttransplantation, survival and migration were significantly greater for HNPCs obtained from the more rostral brain regions. The HNPCs differentiated predominantly into astrocytes after transplantation into the striatum or substantia nigra regions, and thus no behavioral improvement was observed. Conclusions Understanding the regional differences in HNPC properties is prerequisite to their application for PD cell restoration strategies.


2021 ◽  
Vol 31 (Supplement_2) ◽  
Author(s):  
P E F Stricker ◽  
D Souza ◽  
A C Irioda ◽  
C R C Franco ◽  
J R S A Leite ◽  
...  

Abstract Background In Alzheimer's Disease there is an impairment of the cholinergic system, causing loss of neurons, impairment of intellectual abilities. In this context, the mesenchymal stem cells (MSC) and its applications in cell therapies become target of the research, which may contribute to the treatment of neurodegenerative diseases. Through the differentiation potential of MSCs, prospecting functional repair of the injured tissue from cholinergic neuronal cells could be a potential treatment. The aims was to evaluate the possibility of differentiation of MSCs from the human umbilical cord in nestin-positive neural precursor cells (NPCN+) through the NFBX into cholinergic ‘like’ cells. Methods The isolation of hMSCs from Wharton's jelly (WJ) was by the explant and mononuclear cells by density gradient. hMSCs were plating in natural matrix as NFBX for neurospheres production. Neural precursor cells were subjected to standard cholinergic differentiation protocol. Dissociated neurospheres, neural precursor cells and cholinergic-like cells were characterized by immunocytochemistry. The RT-PCR was done. Results hMSCs were CD73+, CD90+, CD105+, CD34- and CD45- and demonstrated the trilineage differentiation. Neurospheres and their isolated cells were nestin positive, and also expressed NESTIN, MAP2, ßIII-TUBULIN, GFAPgenes. Neural precursor cells that were differentiated in cholinergic-like cells expressed ßIII-TUBULIN protein and choline acetyltransferase enzyme. Conclusions hMSCs on the natural matrix were capable of differentiating hMSC into neurospheres, obtaining neural precursor cells without growth factors or gene transfection before cholinergic differentiation.


Sign in / Sign up

Export Citation Format

Share Document